 |
市場調査レポート
商品コード
1448304
乳がん診断の世界市場規模、シェア、成長分析：タイプ別、用途別、製品別 - 産業予測（2024年～2031年）Global Breast Cancer Diagnostics Market Size, Share, Growth Analysis, By Type(Imaging, Biopsy), By Application(Screening, Diagnostic and Predictive), By Product(Hospital, Homecare) - Industry Forecast 2024-2031 |
||||||
| 乳がん診断の世界市場規模、シェア、成長分析：タイプ別、用途別、製品別 - 産業予測（2024年～2031年） |
|
出版日: 2024年03月03日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の乳がん診断の市場規模は、2022年に195億1,000万米ドルとなり、2023年の217億5,000万米ドルから2031年には519億7,000万米ドルに拡大し、予測期間中（2024年～2031年）にCAGR11.5%で成長すると予測されています。
乳がんは、世界中の女性が罹患する一般的ながんの一種であり、初期段階では明確な兆候が見られないことが多いです。この課題に対処するため、乳がん診断市場はAI技術の開発に注力しています。例えば、パラゴン・バイオサイエンシズLLCは、Qlarity Imaging LLCを導入し、放射線学を用いた乳がん診断に役立つAIシステムのFDA承認取得を目指しています。AIを活用することで、この市場の企業は医療成果の大幅な向上を目指しています。AIは様々な種類の画像に利用され、病院や支払者に費用対効果の高いソリューションを提供しています。これらの企業は、使いやすいインターフェースと機械学習機能を備えたAIシステムに投資しており、乳がんの診断と治療の方法を変えています。民間診断センターの世界の増加は、画像診断に対する需要の増加と、画像診断の選択肢が限られている可能性のある公立病院に対する圧力が原動力となっています。富士フイルムは、Dr. Kutty's Healthcareと共同でインドのバンガロールにがん検診センターNURAを開設し、この問題に対処しました。新興諸国では、高額な費用と限られた予算のために、病院が画像診断機器を入手する際の課題に直面しています。一部の病院は、より手頃な選択肢として再生品を選択し、価格は元の費用の約40％から60％です。再生品の人気を見て、シーメンス、GEヘルスケア、フィリップスなどの業界大手は、その使用を促進するプログラムを開始しました。シーメンスのMedical Proven Excellence ProgramやGEヘルスケアのGold Seal Programなど、これらのプログラムは、病院が診断サービスの需要増加に対応できるよう、高品質の画像診断機器をより低価格で提供するものです。
目次
エグゼクティブサマリー
- 市場概要
- 転変
調査手法
- 情報調達
- 二次・一次情報源
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主な市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主な投資の分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
乳がん診断の世界市場：タイプ別
- 市場概要
- イメージング
- 生検
- ゲノム検査
- 血液検査
- その他
乳がん診断の世界市場：用途別
- 市場概要
- スクリーニング
- 診断と予測
- 予後
- その他
乳がん診断の世界市場：製品別
- 市場概要
- 病院
- ホームケア
- 高齢者介護
- その他のヘルスケア環境
乳がん診断の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他欧州
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
- ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
- 中東・アフリカ（MEA）
- GCC諸国
- 南アフリカ
- その他中東・アフリカ
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Hologic, Inc.（United States）
- Siemens Healthineers AG（Germany）
- GE Healthcare（United States）
- Becton, Dickinson and Company（BD）（United States）
- Philips Healthcare（Netherlands）
- Fujifilm Holdings Corporation（Japan）
- Thermo Fisher Scientific（United States）
- Roche Diagnostics（Switzerland）
- Abbott Laboratories（United States）
- Agilent Technologies, Inc.（United States）
Global Breast Cancer Diagnostics Market size was valued at USD 19.51 billion in 2022 and is poised to grow from USD 21.75 billion in 2023 to USD 51.97 billion by 2031, growing at a CAGR of 11.5% in the forecast period (2024-2031).
Breast cancer is a common type of cancer that affects women worldwide, often showing no clear signs in its early stages. To address this challenge, the breast cancer diagnostics market is focusing on developing AI technologies. Paragon Biosciences LLC, for instance, introduced Qlarity Imaging LLC, aiming to get FDA approval for an AI system to help diagnose breast cancer using radiology. By using AI, companies in this market aim to improve medical outcomes significantly. AI is being used in various types of images, offering hospitals and payers cost-effective solutions. These companies are investing in AI systems with easy-to-use interfaces and machine learning capabilities, changing how breast cancer is diagnosed and cared for. The rise in private diagnostic centers globally is driven by the increasing demand for diagnostic imaging and the pressure on public hospitals, which may have limited imaging options. FUJIFILM Corporation addressed this by launching NURA, a cancer screening center in Bangalore, India, in collaboration with Dr. Kutty's Healthcare. In developing countries, hospitals face challenges in getting diagnostic imaging equipment due to high costs and limited budgets. Some hospitals choose refurbished equipment as a more affordable option, priced at about 40% to 60% of the original cost. Seeing the popularity of refurbished devices, industry leaders like Siemens, GE Healthcare, and Philips have started programs to promote their use. These programs, such as Siemens' Medical Proven Excellence Program and GE Healthcare's Gold Seal Program, offer hospitals quality imaging equipment at lower costs, helping them meet the increasing demand for diagnostic services.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Breast Cancer Diagnostic Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Breast Cancer Diagnostic Market Segmental Analysis
Global Breast Cancer Diagnostic Market is segmented on the basis of application end use and region. By application, the market is segmented into handlings, assembling & disassembling, welding & soldering, clean room, dispensing, processing, others. By end use, market is segmented into automotive, electrical, metal machinery, chemical, rubber & plastics, food, others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Breast Cancer Diagnostic Market
New technologies like advanced imaging methods, molecular diagnostics, and biomarker tests have greatly enhanced how breast cancer is detected and diagnosed. These innovations are leading to the use of more advanced diagnostic tools and helping the market grow.
Restraints in the Global Breast Cancer Diagnostic Market
Liquid biopsies, which involve the analysis of circulating tumor cells and cell-free DNA in blood samples, are gaining traction as non-invasive diagnostic tools for breast cancer. These tests offer potential for early detection and monitoring treatment response.
Market Trends of the Global Breast Cancer Diagnostic Market
Liquid biopsies, which analyze circulating tumor cells and cell-free DNA in blood samples, are becoming more popular as non-invasive ways to diagnose breast cancer. These tests have the potential to find cancer early and keep track of how well treatment is working.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Breast Cancer Diagnostics Market by Type
- Market Overview
- Imaging
- Biopsy
- Genomic Tests
- Blood Tests
- Others
Global Breast Cancer Diagnostics Market by Application
- Market Overview
- Screening
- Diagnostic and Predictive
- Prognostic
- Others
Global Breast Cancer Diagnostics Market by Product
- Market Overview
- Hospital
- Homecare
- Elderly Care
- Other Healthcare Settings
Global Breast Cancer Diagnostics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
